Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses

被引:186
作者
Cavani, A [1 ]
Nasorri, F [1 ]
Prezzi, C [1 ]
Sebastiani, S [1 ]
Albanesi, C [1 ]
Girolomoni, G [1 ]
机构
[1] IRCCS, Ist Dermopatico Immacolata, Immunol Lab, I-00167 Rome, Italy
关键词
allergic contact dermatitis; interleukin; 10; regulatory T cells;
D O I
10.1046/j.1523-1747.2000.00881.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The contribution of T helper (Th) and T cytotoxic (Tc) type 1 lymphocytes in the expression of allergic contact dermatitis to haptens has been amply documented. Conversely, the existence of T cell-based regulatory mechanisms has been poorly investigated. Here, we examined the properties of a subset of nickel-specific CD4(+) T cells displaying the cytokine profile (IL-10(+++), IL-5(+++), IFN-gamma(+/-), IL4(+/-)) of T regulatory cells 1 (Tr1) and with;he potential to down-modulate immune responses to nickel. Tr1 clones were isolated from skin challenged with NiSO4 and peripheral blood of nickel-allergic patients, and from the blood of healthy individuals. Tr1 clones expressed CD25, CD28, CD30, CD26, and the IL-12 receptor beta 2 chain upon activation, whereas the lymphocyte activation antigen-3 was present on 50% of the clones. Monocytes precultured with Tr1 cells in the presence of nickel, or treated with Tr1-derived supernatant, exhibited a markedly diminished capacity to stimulate nickel-specific Th1 responses. Tr1 supernatants also blocked the differentiation of dendritic cells (DC) from monocytes, as well as DC maturation and IL-12 production induced by lipopolysaccharide. As a consequence, the ability of DC to stimulate nickel-specific Th1 and Tc1 responses was greatly impaired. These inhibitory effects were completely prevented by IL-10, but not IL-5, neutralization. In aggregate, the results indicate that Tr1 cells can potently regulate the expression of Th1-mediated allergic diseases via release of IL-10.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 63 条
[1]   Role of interleukin 10 in specific immunotherapy [J].
Akdis, CA ;
Blesken, T ;
Akdis, M ;
Wüthrich, B ;
Blaser, K .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :98-106
[2]  
Albanesi C, 1999, J IMMUNOL, V162, P494
[3]  
Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
[4]  
2-4
[5]   Expression and release of LAG-3-encoded protein by human CD4(+) T cells are associated with IFN-gamma production [J].
Annunziato, F ;
Manetti, R ;
Tomasevic, L ;
Giudizi, MG ;
Biagiotti, R ;
Gianno, V ;
Germano, P ;
Mavilia, C ;
Maggi, E ;
Romagnani, S .
FASEB JOURNAL, 1996, 10 (07) :769-776
[6]   Cytokine gene expression during the elicitation phase of contact sensitivity: Regulation by endogenous IL-4 [J].
Asada, H ;
Linton, J ;
Katz, SI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) :406-411
[7]   CIRCULATING ALLERGEN-REACTIVE T-CELLS FROM PATIENTS WITH ATOPIC-DERMATITIS AND ALLERGIC CONTACT-DERMATITIS EXPRESS THE SKIN-SELECTIVE HOMING RECEPTOR, THE CUTANEOUS LYMPHOCYTE-ASSOCIATED ANTIGEN [J].
BABI, LFS ;
PICKER, LJ ;
SOLER, MTP ;
DRZIMALLA, K ;
FLOHR, P ;
BLASER, K ;
HAUSER, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1935-1940
[8]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[9]   INTERLEUKIN-10 BUT NOT INTERLEUKIN-4 IS A NATURAL SUPPRESSANT OF CUTANEOUS INFLAMMATORY RESPONSES [J].
BERG, DJ ;
LEACH, MW ;
KUHN, R ;
RAJEWSKY, K ;
MULLER, W ;
DAVIDSON, NJ ;
RENNICK, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) :99-108
[10]   Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells [J].
Bouloc, A ;
Cavani, A ;
Katz, SI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (01) :44-49